Picture of Voyageur Pharmaceuticals logo

VM Voyageur Pharmaceuticals Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Voyageur Pharmaceuticals, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.

R2019
November 30th
2020
November 30th
2021
November 30th
2022
November 30th
2023
November 30th
Period Length:
Source:Interim ReportARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments0.0760.0030.8130.0320.002
Net Total Accounts Receivable
Net Total Receivables0.0980.0130.0420.0240.036
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.3980.0260.8870.1570.089
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment1.21.241.671.922.06
Other Long Term Assets
Total Assets1.611.282.572.12.16
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.8150.910.6210.5910.674
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities0.8530.9690.6610.6310.728
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity0.7550.3061.911.461.44
Total Liabilities & Shareholders' Equity1.611.282.572.12.16
Total Common Shares Outstanding